News, views and contacts from the global Pharmaceutical industry

Novo Nordisk Pharmatech: Press Releases

Make An Enquiry

Novo Nordisk Pharmatech to Attend CHPI Worldwide in Barcelona Tuesday, September 13, 2016 by Novo Nordisk Pharmatech Novo Nordisk Pharmatech has announced it will be attending CHPI Worldwide to showcase its product portfolio....

Brenntag Specialties Expands Product Offerings with Novo Nordisk Pharmatech Friday, July 01, 2016 by Novo Nordisk Pharmatech Brenntag Specialties (BSI) has signed a distribution agreement for Novo Nordisk Pharmatech's Pharmaceutical Grade Quaternary Ammonium Compounds, to be marketed in the US and Peurto Rican...

Novo Nordisk to Attend BioProcess International European Summit Monday, April 04, 2016 by Novo Nordisk Pharmatech Novo Nordisk will be attending the BioProcess International European Summit from 12-13 April in Vienna,...

Global Supply by Local Distribution Wednesday, May 28, 2014 by Novo Nordisk Pharmatech To provide the best possible customer service, Novo Nordisk Pharmaceuticals now offers distribution from two separate warehouse locations that serve a global client base. One is located...

Novo Nordisk Pharmaceuticals to Attend Biosimilars Asia Monday, May 19, 2014 by Novo Nordisk Pharmatech Novo Nordisk Pharmaceuticals will host a booth at this week's Biosimilars...

Renewal of Novo Nordisk Pharmaceuticals' cGMP certificate Thursday, August 01, 2013 by Novo Nordisk Pharmatech The Danish Medicines Agency has recently renewed its cGMP certificate in accordance with EU GMP Part II (ICH Q7) for an additional three-year...

How Can You Find Quaternary Ammonium Compounds (Quats) That Fit Your Requirements? Friday, June 28, 2013 by Novo Nordisk Pharmatech Quaternary ammonium compounds (Quats) have excellent antimicrobial and surface-active properties, and have a very wide range of applications....

New Rule on Importing Active Pharmaceutical Ingredients (API) to the EU Friday, May 31, 2013 by Novo Nordisk Pharmatech With the enforcement of the European Directive 2011/62/EU relating to medicinal products for human use regarding falsified medicinal products, new requirements are introduced for active...